Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Blackpoint THC
- Development stage
- Unknown
- Lead developer
- Blackpoint Biotech
- Modality
- Small Molecules
- Administration
- Inhalation, Sublingual
01
Overview
BLACKPOINT THC is a medical cannabinoid formulation developed by Blackpoint Biotech. It is designed for delivery via specialized metered-dose consumer devices, specifically a sublingual spray and a THC medical inhaler, which provide consistent, repeatable, and fast-acting doses of delta-9-tetrahydrocannabinol (THC). The formulation contains THC with no cannabidiol (CBD) (5mg:0mg ratio) and is flavored with lemon. As a cannabinoid, THC acts as a partial agonist at the CB1 and CB2 receptors of the endocannabinoid system, which are involved in pain modulation, appetite stimulation, and inflammation regulation. These products are designed to offer patients and healthcare practitioners a reliable and precise alternative to traditional medical cannabis administration methods like vaporization of flower.
- Brand names
- BLACKPOINT THC
- Other names
- Sublingual SprayTHC Medical Inhaler
02
Targets
CNR1 (Cannabinoid receptor 1)GPR55 (G protein-coupled receptor 55)
Beyond the preview
Go deeper on Blackpoint THC.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Blackpoint THC.